Tumors with brisk/non-brisk tumor-infiltrating lymphocytes (TIL) vs. absence of TIL exhibited significantly higher levels of APRIL/TNFSF13 (p = 0.01), CCL19 (p = 0.01) and CXCL13 (p = 0.01), but no such difference was observed for patients’ serum levels of CXCL10 (p = 0.97) (Figure S1). Here, CXCL10 is linked to neoplasm.